Michael Doubek
Michael Doubek publishes mostly in Genetics, Hematology and Pathology and Forensic Medicine, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Acute Lymphoblastic Leukemia research.
- World rank
- #4,958,229 of 7,710,434 ranked researchers
- Rank in Czechia
- #16,901 of 39,303
- Works
- 822
- Citations
- 7.8k
- Citations per work
- 9.5
What does Michael Doubek research?
Michael Doubek's work is mostly in Medicine (52%), Immunology and Microbiology (9%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences42751.9%
- Medicine42751.9%
- Everything else25631.2%
- Life Sciences13916.9%
- 1Genetics25% of their works
- 2Hematology12% of their works
- 3Pathology and Forensic Medicine9% of their works
- 4Immunology9% of their works
- 5Molecular Biology8% of their works
- 6Public Health, Environmental and Occupational Health6% of their works
Research topics
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
- Chronic Myeloid Leukemia Treatments
- Immunodeficiency and Autoimmune Disorders
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Glycosylation and Glycoproteins Research
Which keywords describe Michael Doubek's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, Lymphoma, Acute Lymphoblastic Leukemia and Childhood Cancer.
- Glycosylation
- Myelofibrosis
- Acute Myeloid Leukemia
- Primary Immunodeficiency
- Imatinib
- Childhood Cancer
- Lymphoma
- Genomic Aberrations
- Rituximab
- Prognostic Factors
- Chronic Lymphocytic Leukemia
- Classification
- Acute Lymphoblastic Leukemia
- BCR-ABL
- Genetic Mutations
- AML
- JAK2 Mutation
- Glycans
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Prognostic Factors6003 topics
- Rituximab5872 topics
- Chronic Lymphocytic Leukemia4321 topic
- Genomic Aberrations4321 topic
- Classification1551 topic
- Lymphoma1551 topic
- Acute Lymphoblastic Leukemia1081 topic
- Childhood Cancer1081 topic
- BCR-ABL941 topic
- Imatinib941 topic
- Genetic Mutations771 topic
- Primary Immunodeficiency771 topic
- AML601 topic
- Acute Myeloid Leukemia601 topic
- JAK2 Mutation431 topic
- Myelofibrosis431 topic
- Glycans391 topic
- Glycosylation391 topic
Where does Michael Doubek work?
Michael Doubek's main affiliation in the publication record is University Hospital Brno, Czechia.
How many publications and citations does Michael Doubek have?
OpenAlex counts 822 works and 7,802 citations for Michael Doubek, an h-index of 44, ranking #4,958,229 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Michael Doubek
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Doubek. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.